345 related articles for article (PubMed ID: 19774677)
1. Decreased levels of PSD95 and two associated proteins and increased levels of BCl2 and caspase 3 in hippocampus from subjects with amnestic mild cognitive impairment: Insights into their potential roles for loss of synapses and memory, accumulation of Abeta, and neurodegeneration in a prodromal stage of Alzheimer's disease.
Sultana R; Banks WA; Butterfield DA
J Neurosci Res; 2010 Feb; 88(3):469-77. PubMed ID: 19774677
[TBL] [Abstract][Full Text] [Related]
2. Redox proteomics analysis of brains from subjects with amnestic mild cognitive impairment compared to brains from subjects with preclinical Alzheimer's disease: insights into memory loss in MCI.
Aluise CD; Robinson RA; Cai J; Pierce WM; Markesbery WR; Butterfield DA
J Alzheimers Dis; 2011; 23(2):257-69. PubMed ID: 20930294
[TBL] [Abstract][Full Text] [Related]
3. Alteration of mTOR signaling occurs early in the progression of Alzheimer disease (AD): analysis of brain from subjects with pre-clinical AD, amnestic mild cognitive impairment and late-stage AD.
Tramutola A; Triplett JC; Di Domenico F; Niedowicz DM; Murphy MP; Coccia R; Perluigi M; Butterfield DA
J Neurochem; 2015 Jun; 133(5):739-49. PubMed ID: 25645581
[TBL] [Abstract][Full Text] [Related]
4. Oxidative modification to LDL receptor-related protein 1 in hippocampus from subjects with Alzheimer disease: implications for Aβ accumulation in AD brain.
Owen JB; Sultana R; Aluise CD; Erickson MA; Price TO; Bu G; Banks WA; Butterfield DA
Free Radic Biol Med; 2010 Dec; 49(11):1798-803. PubMed ID: 20869432
[TBL] [Abstract][Full Text] [Related]
5. Xanthoceras sorbifolia extracts ameliorate dendritic spine deficiency and cognitive decline via upregulation of BDNF expression in a rat model of Alzheimer's disease.
Li Y; Xu J; Xu P; Song S; Liu P; Chi T; Ji X; Jin G; Qiu S; Hou Y; Zheng C; Wang L; Meng D; Zou L
Neurosci Lett; 2016 Aug; 629():208-214. PubMed ID: 27412235
[TBL] [Abstract][Full Text] [Related]
6. Alzheimer's therapeutics targeting amyloid beta 1-42 oligomers II: Sigma-2/PGRMC1 receptors mediate Abeta 42 oligomer binding and synaptotoxicity.
Izzo NJ; Xu J; Zeng C; Kirk MJ; Mozzoni K; Silky C; Rehak C; Yurko R; Look G; Rishton G; Safferstein H; Cruchaga C; Goate A; Cahill MA; Arancio O; Mach RH; Craven R; Head E; LeVine H; Spires-Jones TL; Catalano SM
PLoS One; 2014; 9(11):e111899. PubMed ID: 25390692
[TBL] [Abstract][Full Text] [Related]
7. Progressive accumulation of amyloid-beta oligomers in Alzheimer's disease and in amyloid precursor protein transgenic mice is accompanied by selective alterations in synaptic scaffold proteins.
Pham E; Crews L; Ubhi K; Hansen L; Adame A; Cartier A; Salmon D; Galasko D; Michael S; Savas JN; Yates JR; Glabe C; Masliah E
FEBS J; 2010 Jul; 277(14):3051-67. PubMed ID: 20573181
[TBL] [Abstract][Full Text] [Related]
8. Assessment of ZnT3 and PSD95 protein levels in Lewy body dementias and Alzheimer's disease: association with cognitive impairment.
Whitfield DR; Vallortigara J; Alghamdi A; Howlett D; Hortobágyi T; Johnson M; Attems J; Newhouse S; Ballard C; Thomas AJ; O'Brien JT; Aarsland D; Francis PT
Neurobiol Aging; 2014 Dec; 35(12):2836-2844. PubMed ID: 25104558
[TBL] [Abstract][Full Text] [Related]
9. Oxidative stress and hippocampal synaptic protein levels in elderly cognitively intact individuals with Alzheimer's disease pathology.
Scheff SW; Ansari MA; Mufson EJ
Neurobiol Aging; 2016 Jun; 42():1-12. PubMed ID: 27143416
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of wild-type human APP in mice causes cognitive deficits and pathological features unrelated to Abeta levels.
Simón AM; Schiapparelli L; Salazar-Colocho P; Cuadrado-Tejedor M; Escribano L; López de Maturana R; Del Río J; Pérez-Mediavilla A; Frechilla D
Neurobiol Dis; 2009 Mar; 33(3):369-78. PubMed ID: 19101630
[TBL] [Abstract][Full Text] [Related]
11. Alterations in zinc transporter protein-1 (ZnT-1) in the brain of subjects with mild cognitive impairment, early, and late-stage Alzheimer's disease.
Lovell MA; Smith JL; Xiong S; Markesbery WR
Neurotox Res; 2005; 7(4):265-71. PubMed ID: 16179263
[TBL] [Abstract][Full Text] [Related]
12. Dysregulated phosphorylation of Ca(2+) /calmodulin-dependent protein kinase II-α in the hippocampus of subjects with mild cognitive impairment and Alzheimer's disease.
Reese LC; Laezza F; Woltjer R; Taglialatela G
J Neurochem; 2011 Nov; 119(4):791-804. PubMed ID: 21883216
[TBL] [Abstract][Full Text] [Related]
13. Time-dependent effect of oligomeric amyloid-β (1-42)-induced hippocampal neurodegeneration in rat model of Alzheimer's disease.
Karthick C; Nithiyanandan S; Essa MM; Guillemin GJ; Jayachandran SK; Anusuyadevi M
Neurol Res; 2019 Feb; 41(2):139-150. PubMed ID: 30453864
[TBL] [Abstract][Full Text] [Related]
14. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
15. Collaboration of geldanamycin-activated P70S6K and Hsp70 against beta-amyloid-induced hippocampal apoptosis: an approach to long-term memory and learning.
Zare N; Motamedi F; Digaleh H; Khodagholi F; Maghsoudi N
Cell Stress Chaperones; 2015 Mar; 20(2):309-19. PubMed ID: 25576151
[TBL] [Abstract][Full Text] [Related]
16. Quantitative phosphoproteomic analyses of the inferior parietal lobule from three different pathological stages of Alzheimer's disease.
Triplett JC; Swomley AM; Cai J; Klein JB; Butterfield DA
J Alzheimers Dis; 2016; 49(1):45-62. PubMed ID: 26444780
[TBL] [Abstract][Full Text] [Related]
17. Protein levels and activity of some antioxidant enzymes in hippocampus of subjects with amnestic mild cognitive impairment.
Sultana R; Piroddi M; Galli F; Butterfield DA
Neurochem Res; 2008 Dec; 33(12):2540-6. PubMed ID: 18320305
[TBL] [Abstract][Full Text] [Related]
18. Proteomics-determined differences in the concanavalin-A-fractionated proteome of hippocampus and inferior parietal lobule in subjects with Alzheimer's disease and mild cognitive impairment: implications for progression of AD.
Owen JB; Di Domenico F; Sultana R; Perluigi M; Cini C; Pierce WM; Butterfield DA
J Proteome Res; 2009 Feb; 8(2):471-82. PubMed ID: 19072283
[TBL] [Abstract][Full Text] [Related]
19. Elevated levels of 3-nitrotyrosine in brain from subjects with amnestic mild cognitive impairment: implications for the role of nitration in the progression of Alzheimer's disease.
Butterfield DA; Reed TT; Perluigi M; De Marco C; Coccia R; Keller JN; Markesbery WR; Sultana R
Brain Res; 2007 May; 1148():243-8. PubMed ID: 17395167
[TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein E/Amyloid-β Complex Accumulates in Alzheimer Disease Cortical Synapses via Apolipoprotein E Receptors and Is Enhanced by APOE4.
Bilousova T; Melnik M; Miyoshi E; Gonzalez BL; Poon WW; Vinters HV; Miller CA; Corrada MM; Kawas C; Hatami A; Albay R; Glabe C; Gylys KH
Am J Pathol; 2019 Aug; 189(8):1621-1636. PubMed ID: 31108099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
